logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Cyclophosphamide/hydroxychloroquine/prednisoloneLack of efficacy following off-label use : case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2024年 / 2019卷 / 1期
关键词:
D O I:
10.1007/s40278-024-64057-5
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:144 / 144
相关论文
共 50 条
  • [31] RuxolitinibLack of efficacy following off-label use: case report
    Reactions Weekly, 2024, 2039 (1) : 502 - 502
  • [32] EribulinLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1921 (1) : 135 - 135
  • [33] ImiquimodLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1920 (1) : 254 - 254
  • [34] IbrutinibLack of efficacy following off-label use: case report
    Reactions Weekly, 2025, 2042 (1) : 209 - 209
  • [35] InterferonLack of efficacy following off-label use: case report
    Reactions Weekly, 2024, 2025 (1) : 231 - 231
  • [36] VedolizumabLack of efficacy following off-label use: case report
    Reactions Weekly, 2023, 1938 (1) : 1250 - 1250
  • [37] TocilizumabLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1887 (1) : 643 - 643
  • [38] DexamethasoneLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1936 (1) : 195 - 195
  • [39] ApixabanLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1935 (1) : 89 - 89
  • [40] CabazitaxelLack of efficacy following off-label use: case report
    Reactions Weekly, 2023, 1980 (1) : 102 - 102
← 12345 →